Role of pharmacist in diabetes management at community pharmacy

Authors
Category Primary study
Registry of TrialsISRCTN registry
Year 2017
INTERVENTION: Simple random sampling was used for the participants. There are different intervention strategies for the control and the experimental group: 1. The control group received routine medications and dietary plan and no intervention was applied. 2. The experimental group received interventions about self‐management, quality of life, medication adherence, glycemic control and knowledge about the disease. Intervention related information was provided through a diet chart, a foot care chart, and a hypo‐ and hyper‐glycemic chart, and the importance of exercise and medication by verbal conversation with the participants. The total duration of intervention and follow‐up was up to 1 month from the date of registration into the trial. CONDITION: Type 2 diabetes mellitus ; Nutritional, Metabolic, Endocrine ; Type 2 diabetes mellitus PRIMARY OUTCOME: 1. Glycemic control, measured using the strip method Accu check performa meter at baseline and after the completion of 1 month of intervention ; 2. Patient satisfaction about the services provided during trial, measured using the DDSM‐Q after the completion of 1 month of intervention SECONDARY OUTCOME: 1. Perception of self‐management of diabetes, measured using the DDSM‐Q; 2. Disease state knowledge, measured using the DDSM‐Q; 3. Quality of life, measured using the EQ‐5D‐3L; 4. Medication adherence, measured using the MMAS; Measured at baseline and after completion of 1 month of intervention; INCLUSION CRITERIA: 1. Patients with type 2 diabetes mellitus (T2DM) diagnosed by a registered medical practitioner 2. Minimum one year T2DM history 3. Age 18‐70 years 4. On anti‐diabetes therapy 5. Co‐morbidity may or may not be present 6. Minimum two follow‐up visits within one month period from the date of registration in trial 7. Both male and female
Epistemonikos ID: 8fd0b702b2df6cb398e7b4984f251ec1144d860c
First added on: Aug 23, 2024